Good pipeline, good drug candidates.

Recent positive articles in Business Week and Michigan Business Review have me believing their leading drug candidate could have more utility than originally thought.

I came across this stock when looking into the Bio-technology industry. Interestingly enough, the first article i read had to do with a potential drug treatment for Multiple Sclerosis. My wife has MS, so i was emotionally interested (not that i would recommend investing on purely emotional basis). The Company potentially has an oral (pill) solution/treatment for Women MS patients. If this drug gets approved and is able to make it to the market, it will replace all current medications (which btw... require patients to inject themselves daily - every other day).

Also, the 52 wk high for this stock was $30. It's a risky stock pick, but the rewards can be 5x.